Home / Inspections / 1006752

FDA Inspection 1006752 — NewYork-Presbyterian Columbia Irving Medical Center

NewYork-Presbyterian Columbia Irving Medical Center — FEI 2474233

The FDA completed an inspection of NewYork-Presbyterian Columbia Irving Medical Center on April 6, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1325654 (NAI Thu Jul 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1223803 (VAI Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1086853 (NAI Wed Apr 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905645 (VAI Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816284 (NAI Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources